UBS (UBS) Tops Q3 Earnings and Revenue Estimates

30.10.24 12:05 Uhr

Werte in diesem Artikel
Aktien

26,89 CHF -0,93 CHF -3,34%

Indizes

1.188,1 PKT -22,9 PKT -1,89%

7.657,5 PKT 16,8 PKT 0,22%

1.888,6 PKT -38,7 PKT -2,01%

11.414,8 PKT -224,1 PKT -1,93%

1.569,3 PKT -29,5 PKT -1,84%

15.230,2 PKT -278,0 PKT -1,79%

1.775,3 PKT -34,1 PKT -1,88%

4.320,9 PKT -70,0 PKT -1,59%

15.101,7 PKT -275,9 PKT -1,79%

UBS (UBS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 53.57%. A quarter ago, it was expected that this bank would post earnings of $0.12 per share when it actually produced earnings of $0.34, delivering a surprise of 183.33%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.UBS, which belongs to the Zacks Banks - Foreign industry, posted revenues of $12.33 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 10.16%. This compares to year-ago revenues of $11.7 billion. The company has topped consensus revenue estimates three times over the last four quarters.The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.UBS shares have added about 6.2% since the beginning of the year versus the S&P 500's gain of 22.3%.What's Next for UBS?While UBS has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.Ahead of this earnings release, the estimate revisions trend for UBS: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.16 on $11.19 billion in revenues for the coming quarter and $1.35 on $47.06 billion in revenues for the current fiscal year.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Foreign is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.One other stock from the same industry, Credicorp (BAP), is yet to report results for the quarter ended September 2024. The results are expected to be released on November 7.This Peruvian finance company is expected to post quarterly earnings of $4.67 per share in its upcoming report, which represents a year-over-year change of +10.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.Credicorp's revenues are expected to be $1.36 billion, up 7.6% from the year-ago quarter.Should You Invest in UBS Group AG (UBS)?Before you invest in UBS Group AG (UBS), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UBS Group AG (UBS): Free Stock Analysis Report Credicorp Ltd. (BAP): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Tops

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Tops

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UBS

Analysen zu UBS

DatumRatingAnalyst
06.12.2024UBS OverweightJP Morgan Chase & Co.
29.11.2024UBS OutperformRBC Capital Markets
27.11.2024UBS OutperformRBC Capital Markets
31.10.2024UBS HoldDeutsche Bank AG
31.10.2024UBS BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
06.12.2024UBS OverweightJP Morgan Chase & Co.
29.11.2024UBS OutperformRBC Capital Markets
27.11.2024UBS OutperformRBC Capital Markets
31.10.2024UBS BuyGoldman Sachs Group Inc.
31.10.2024UBS OutperformRBC Capital Markets
DatumRatingAnalyst
31.10.2024UBS HoldDeutsche Bank AG
08.10.2024UBS HoldDeutsche Bank AG
27.08.2024UBS HoldDeutsche Bank AG
22.08.2024UBS HoldJefferies & Company Inc.
15.08.2024UBS HoldDeutsche Bank AG
DatumRatingAnalyst
23.04.2024UBS UnderweightBarclays Capital
09.02.2024UBS UnderweightBarclays Capital
06.02.2024UBS UnderweightBarclays Capital
19.01.2024UBS UnderweightBarclays Capital
07.11.2023UBS UnderweightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UBS nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"